Medical Disorders
Resources
Basic InformationLookupsLatest News
Managing Seasonal AllergiesControl of Heart Risks May Vary Among Outpatient PracticesFDA Approves Simponi for Ulcerative ColitisUltrasound Findings Can Improve Classification of RAHealth Tip: Exercise With Allergies and AsthmaCombo Drug Therapy May Work Best to Strengthen Bones: StudyCDC Guidelines Could Cut Bloodstream Infections From DialysisUnusual Heat May Have Boosted West Nile Virus Last Year: CDCGood Diet Helps People Manage Celiac DiseaseExercise May Ease Pain of Fibromyalgia, Study SuggestsDog DNA May Yield Clues to Human EczemaAUA: Primary Care Treatment for UTI Could Save $2 BillionHealth Tip: Lactose May Be Hiding in FoodResearchers Pinpoint Cause of Port-Wine Stain BirthmarksHigh Blood Sugar May Add to Alzheimer's Risk: StudySome Antidepressants May Raise Risk for Gastro InfectionHealth Tip: Coping With Shoulder ArthritisOmega-3s No Help Against Age-Linked Eye Trouble: Study1997 to 2011 Saw Increase in Allergies Among U.S. ChildrenMild Hyperthyroidism Tied to Higher Death RiskHealth Tip: Help Prevent Exercise-Induced AsthmaFirst Aid Tips for Treating Cuts, Scrapes and Puncture WoundsFood, Skin Allergies on the Rise Among Children: CDCPenicillin Prevents Return of Leg Infection Called Cellulitis: StudyAntibiotic Azithromycin Won't Harm Healthy Hearts: StudyFDA: Samsca May Cause Liver DamageStudy Debunks Lyme Disease-Autism LinkParalyzed Patient Moves Prosthetic Arm With Her MindSome Antidepressants Linked to Bleeding Risk With SurgeryAllergies: As American as Apple Pie?Drugs Can Sometimes Prevent Migraines, but at a CostReview: All Approved Drugs Similarly Prevent MigrainesAlmost Half of Americans Would Consider Donating Kidney to Stranger: PollAir Pollution Linked to Marker of AtherosclerosisTeens Targeting Strength, Cardio Fitness Battle Insulin ResistanceHealth Tip: Why Did I Faint?Ingredient in New MS Drug Linked to Serious Brain Disease'Gut Reaction' May Predict Cardiovascular RiskAsthma Health Care Access Worse for Young AdultsImpact of Childhood Bacterial Meningitis Lasts Into AdulthoodAmerican Lung Association Stresses Clean Air Act BenefitsBlood Test May Catch Deadly Fungal Infection Quickly'Off-the-Shelf' Artificial Blood Vessels Show PromiseSofosbuvir Shows Promise for Chronic Hepatitis C InfectionDeadly Meningitis Cases Worry Gay CommunityFiguring Out Your Migraine Triggers Is TrickyBreathing Problem Sometimes Misdiagnosed in Athletes'Mobility Shoes' May Help Those With Arthritic Knees: StudyHealth Tip: Should I See a Doctor for Pinkeye?Belly Fat May Be Tied to Kidney Damage
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health
Heart Disease

New Guidelines Issued for Management of Gout


HealthDay News
Updated: Oct 2nd 2012

new article illustration

TUESDAY, Oct. 2 (HealthDay News) -- Approaches for management of gout are presented in a two-part guideline issued by the American College of Rheumatology (ACR) and published online Sept. 28 in Arthritis Care & Research.

In part one, Dinesh Khanna, M.D., from the University of Michigan in Ann Arbor, and colleagues from the ACR reviewed the literature to examine the systematic non-pharmacologic and pharmacologic recommendations for management of hyperuricemia. The authors provide general health, diet, and lifestyle measures for all gout patients. A xanthine oxidase inhibitor, such as allopurinol, should be considered the first-line urate-lowering pharmacological approach to reduce urate levels to less than 6 mg/dL. The recommended initial dose should not exceed 100 mg/day and should be less for patients with moderate to severe chronic kidney disease. Screening for HLA-B*5801 should be considered for patients at high-risk of allopurinol reactions. When target urate levels are not achieved, combination therapy is recommended with one xanthine oxidase inhibitor and one uricosuric agent. For uricosuric monotherapy, probenecid is the first-choice agent.

In part two, Khanna and colleagues review management approaches for treatment and prophylaxis for acute gout attacks. They recommend initiating pharmacologic therapy within 24 hours of attack onset. Urate-lowering therapy should be continued during attacks. First-line treatment options for acute gout include use of one or a combination of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or oral colchicine. When initiating urate-lowering therapy, oral colchicine or low-dose NSAIDs should be used as anti-inflammatory prophylaxis to prevent acute gout attacks.

"Our goal is that these guidelines, along with educating gout patients in effective treatment, will improve adherence, quality of care, and management of this painful and potentially chronically debilitating condition," a coauthor said in a statement.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract - Part 1
Full Text (subscription or payment may be required)
Abstract - Part 2
Full Text (subscription or payment may be required)

This article: Copyright © 2012 HealthDay. All rights reserved.